NK 341
Alternative Names: NK341Latest Information Update: 21 Aug 2007
At a glance
- Originator Nippon Kayaku
- Class Anti-ischaemics; Antiarrhythmics; Ischaemic heart disorder therapies
- Mechanism of Action Superoxide dismutase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Ischaemic heart disorders